Upregulation of efrAB efflux pump among Enterococcus faecalis ST480, ST847 in Iran.
暂无分享,去创建一个
A. Pourmohammad | M. Goudarzi | L. Azimi | A. Hashemi | Seyedeh Marzieh Jabbari Shiadeh | T. Azimi | Bahare Gholami Chaboki
[1] X. Giannakopoulos,et al. Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[2] R. Hage,et al. Emerging Antibiotic Resistance to Bacterial Isolates from Human Urinary Tract Infections in Grenada , 2019, Cureus.
[3] Qi Wang,et al. Molecular characteristics of oxazolidinone resistance in enterococci from a multicenter study in China , 2019, BMC Microbiology.
[4] R. Bonnet,et al. Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16. , 2019, The Journal of antimicrobial chemotherapy.
[5] Chunni Zhang,et al. Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China. , 2019, Journal of global antimicrobial resistance.
[6] P. Lak,et al. First detection of efrAB, an ABC multidrug efflux pump in Enterococcus faecalis in Tehran, Iran. , 2018, Acta microbiologica et immunologica Hungarica.
[7] D. Anderson,et al. Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection , 2018, Infection Control & Hospital Epidemiology.
[8] T. Perera,et al. Vancomycin-Resistant Enterococci (VRE) , 2018 .
[9] T. Shirakawa,et al. International Comparison of Causative Bacteria and Antimicrobial Susceptibilities of Urinary Tract Infections between Kobe, Japan, and Surabaya, Indonesia. , 2018, Japanese journal of infectious diseases.
[10] M. Pfaller,et al. ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries , 2017, The Journal of antimicrobial chemotherapy.
[11] F. Moges,et al. Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital , 2017, BMC Infectious Diseases.
[12] D. Tieleman,et al. The Heterodimeric ABC Transporter EfrCD Mediates Multidrug Efflux in Enterococcus faecalis , 2016, Antimicrobial Agents and Chemotherapy.
[13] A. Boudabous,et al. Diversity of enterococcal species and characterization of high-level aminoglycoside resistant enterococci of samples of wastewater and surface water in Tunisia. , 2015, The Science of the total environment.
[14] M. Pourshafie,et al. Antibiotic Resistance and Biofilm Formation of Enterococcus faecalis in Patient and Environmental Samples , 2015, Jundishapur journal of microbiology.
[15] P. Gutiérrez-Castrellón,et al. [Efficacy and safety of ciprofloxacin treatment in urinary tract infections (UTIs) in adults: a systematic review with meta-analysis]. , 2015, Gaceta medica de Mexico.
[16] X. Shang,et al. Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns , 2015, Journal of chemotherapy.
[17] N. Benomar,et al. Role of EfrAB efflux pump in biocide tolerance and antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from traditional fermented foods and the effect of EDTA as EfrAB inhibitor. , 2014, Food microbiology.
[18] A. Lo Nostro,et al. Prevalence and antibiotic resistance of Enterococcus spp. isolated from retail cheese, ready-to-eat salads, ham, and raw meat. , 2014, Food microbiology.
[19] So-Jung Kang,et al. Distribution of Multidrug Efflux Pump Genes in Enterococci spp. Isolated from Bovine Milk Samples and Their Antibiotic Resistance Patterns , 2013 .
[20] Gilho Lee. Ciprofloxacin Resistance in Enterococcus faecalis Strains Isolated From Male Patients With Complicated Urinary Tract Infection , 2013, Korean journal of urology.
[21] N. Benomar,et al. Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods. , 2013, Foodborne pathogens and disease.
[22] A. Sundsfjord,et al. Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. , 2012, The Journal of antimicrobial chemotherapy.
[23] T. Shirakawa,et al. Mechanisms of and Risk Factors for Fluoroquinolone Resistance in Clinical Enterococcus faecalis Isolates from Patients with Urinary Tract Infections , 2011, Journal of Clinical Microbiology.
[24] P. Sorgeloos,et al. Alternatives to antibiotics for the control of bacterial disease in aquaculture. , 2011, Current opinion in microbiology.
[25] M. Yasuda,et al. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). , 2011, International journal of antimicrobial agents.
[26] Clsi. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .
[27] V. Ferreira,et al. Antibiotic susceptibility of enterococci isolated from traditional fermented meat products. , 2009, Food microbiology.
[28] A. Afifi,et al. Prevalence of Multidrug Resistant Enterococci in Nosocomial Infection In Gaza Strip , 2008 .
[29] A. Driessen,et al. Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria , 2007, Microbiology and Molecular Biology Reviews.
[30] Oliver Hendricks,et al. Reversal of resistance in microorganisms by help of non-antibiotics. , 2007, The Journal of antimicrobial chemotherapy.
[31] A. Hasan,et al. Resistance patterns of urinary isolates in a tertiary Indian hospital. , 2007, Journal of Ayub Medical College, Abbottabad : JAMC.
[32] Janetta Top,et al. Multilocus Sequence Typing Scheme for Enterococcus faecalis Reveals Hospital-Adapted Genetic Complexes in a Background of High Rates of Recombination , 2006, Journal of Clinical Microbiology.
[33] D. Levine,et al. Vancomycin: a history. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] H. Schweizer,et al. Bacterial resistance to antibiotics: active efflux and reduced uptake. , 2005, Advanced drug delivery reviews.
[35] Arto S. Baghdayan,et al. Enterococcal Surface Protein, Esp, Enhances Biofilm Formation by Enterococcus faecalis , 2004, Infection and Immunity.
[36] R. Wenzel,et al. Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility , 2022 .
[37] T. Tsuchiya,et al. EfrAB, an ABC Multidrug Efflux Pump in Enterococcus faecalis , 2003, Antimicrobial Agents and Chemotherapy.
[38] M. Gilmore,et al. Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. , 2002, Microbes and infection.
[39] L. Mandell,et al. Safety of fluoroquinolones: An update. , 2002, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[40] K. Lewis. In search of natural substrates and inhibitors of MDR pumps. , 2001, Journal of molecular microbiology and biotechnology.
[41] G. Weinstock,et al. Enterococcus faecalis multi-drug resistance transporters: application for antibiotic discovery. , 2001, Journal of molecular microbiology and biotechnology.
[42] M. Gilmore,et al. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. , 1998, Emerging infectious diseases.
[43] M. Saier,et al. Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport , 1994, Molecular microbiology.
[44] R. Kolter,et al. ABC transporters: bacterial exporters , 1993, Microbiological reviews.
[45] C. Higgins,et al. ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.
[46] S. Levy,et al. Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.